{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:21:42Z","timestamp":1775820102636,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate how recommendations of European guidelines regarding pharmacological and non-pharmacological treatments for heart failure (HF) are adopted in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The ESC-HF Long-Term Registry is a prospective, observational study conducted in 211 Cardiology Centres of 21 European and Mediterranean countries, members of the European Society of Cardiology (ESC). From May 2011 to April 2013, a total of 12 440 patients were enrolled, 40.5% with acute HF and 59.5% with chronic HF. Intravenous treatments for acute HF were heterogeneously administered, irrespective of guideline recommendations. In chronic HF, with reduced EF, renin\u2013angiotensin system (RAS) blockers, beta-blockers, and mineralocorticoid antagonists (MRAs) were used in 92.2, 92.7, and 67.0% of patients, respectively. When reasons for non-adherence were considered, the real rate of undertreatment accounted for 3.2, 2.3, and 5.4% of the cases, respectively. About 30% of patients received the target dosage of these drugs, but a documented reason for not achieving the target dosage was reported in almost two-thirds of them. The more relevant reasons for non-implantation of a device, when clinically indicated, were related to doctor uncertainties on the indication, patient refusal, or logistical\/cost issues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This pan-European registry shows that, while in patients with acute HF, a large heterogeneity of treatments exists, drug treatment of chronic HF can be considered largely adherent to recommendations of current guidelines, when the reasons for non-adherence are taken into account. Observations regarding the real possibility to adhere fully to current guidelines in daily clinical practice should be seriously considered when clinical practice guidelines have to be written.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hft134","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T21:04:40Z","timestamp":1377551080000},"page":"1173-1184","source":"Crossref","is-referenced-by-count":556,"title":["Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry"],"prefix":"10.1093","volume":"15","author":[{"given":"Aldo P.","family":"Maggioni","sequence":"first","affiliation":[{"name":"ANMCO Research Center , Florence ,","place":["Italy"]}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology, Charit\u00e9 Medical School, Campus Virchow-Klinikum , Berlin ,","place":["Germany"]}]},{"given":"Ulf","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Linkoping University Hospital , Linkoping ,","place":["Sweden"]}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Athens University Hospital Attikon , Athens ,","place":["Greece"]}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Military Hospital , Wroclaw ,","place":["Poland"]}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[{"name":"Inserm, Centre d\u2019Investigation Cliniques CIC 9501 and U961, CHU and Department of Cardiology, Nancy University , Nancy ,","place":["France"]}]},{"given":"Offer","family":"Amir","sequence":"additional","affiliation":[{"name":"Lady Davis Carmel Medical Centre \u00a0","place":["Israel"]}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[{"name":"Cardiology 1, Institut de Boli Cardiovasculare C.C. Iliescu , Bucuresti ,","place":["Romania"]}]},{"given":"Marisa Crespo","family":"Leiro","sequence":"additional","affiliation":[{"name":"Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Hospital Universitario A Coru\u00f1a , La Coru\u00f1a ,","place":["Spain"]}]},{"given":"Jaroslaw","family":"Drozdz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Lodz , Lodz ,","place":["Poland"]}]},{"given":"Andrejs","family":"Erglis","sequence":"additional","affiliation":[{"name":"Pauls Stradins Clinical University Hospital , Riga ,","place":["Latvia"]}]},{"given":"Emir","family":"Fazlibegovic","sequence":"additional","affiliation":[{"name":"Clinical Hospital Mostar , Mostar ,","place":["Bosnia Herzegovina"]}]},{"given":"Candida","family":"Fonseca","sequence":"additional","affiliation":[{"name":"S. Francisco Xavier Hospital, New University of Lisbon , Lisbon ,","place":["Portugal"]}]},{"given":"Friedrich","family":"Fruhwald","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University , Graz ,","place":["Austria"]}]},{"given":"Plamen","family":"Gatzov","sequence":"additional","affiliation":[{"name":"University Hospital Lozenets , Sofia ,","place":["Bulgaria"]}]},{"given":"Eva","family":"Goncalvesova","sequence":"additional","affiliation":[{"name":"National Institute of Cardiovasc Diseases\u2013NUSCH, Bratislava \u00a0","place":["Slovak Republic"]}]},{"given":"Mahmoud","family":"Hassanein","sequence":"additional","affiliation":[{"name":"Alexandria University , Alexandria ,","place":["Egypt"]}]},{"given":"Jaromir","family":"Hradec","sequence":"additional","affiliation":[{"name":"3rd Dept of Medicine, Faculty General Hospital, Charles University , Prague ,","place":["Czech Republic"]}]},{"given":"Ausra","family":"Kavoliuniene","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lithuanian University of Health Sciences , Kaunas ,","place":["Lithuania"]}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik , Golnik ,","place":["Slovenia"]}]},{"given":"Damien","family":"Logeart","sequence":"additional","affiliation":[{"name":"Department of Cardiology, INSERM UMR 942, Lariboisi\u00e8re Hospital , Paris ,","place":["France"]}]},{"given":"Bela","family":"Merkely","sequence":"additional","affiliation":[{"name":"Semmelweis University, Heart Center , Budapest ,","place":["Hungary"]}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cattedra di Cardiologia, Dipartimento di medicina sperimentale ed applicata, Spedali Civili, Universit\u00e0 di Brescia , Brescia ,","place":["Italy"]}]},{"given":"Hans","family":"Persson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Danderyd University Hospital , Stockholm ,","place":["Sweden"]}]},{"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical Centre of Serbia , Belgrade ,","place":["Serbia"]}]},{"given":"Ahmet","family":"Temizhan","sequence":"additional","affiliation":[{"name":"Turkey Y\u00fcksek Ihtisas Hospital, Cardiology Clinic , Ankara ,","place":["Turkey"]}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Athens University Medical School , Athens ,","place":["Greece"]}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation , Cotignola ,","place":["Italy"]}]}],"member":"286","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"2026011921160683400_ejhfhft134-bib-0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/CIRCHEARTFAILURE.112.000161","article-title":"Multicenter prospective observational study on acute and chronic heart failure: the one-year follow-up results of IN-HF outcome registry","volume":"6","author":"Tavazzi","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0002","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0003","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people","volume":"119","author":"Jhund","year":"2009","journal-title":"Circulation"},{"key":"2026011921160683400_ejhfhft134-bib-0004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ehj.2003.12.012","article-title":"Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000","volume":"25","author":"Schaufelberger","year":"2004","journal-title":"Eur Heart J"},{"key":"2026011921160683400_ejhfhft134-bib-0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0006","first-page":"803","article-title":"Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0007","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","article-title":"2009 focused update: ACCF\/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"2026011921160683400_ejhfhft134-bib-0008","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/eurjhf\/hfq192","article-title":"Committee for Practice Guidelines of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy","volume":"12","author":"Dickstein","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMsa043778","article-title":"Quality of care in U.S. hospitals as reflected by standardized measures, 2002\u20132004","volume":"353","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"key":"2026011921160683400_ejhfhft134-bib-0010","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.165.13.1469","article-title":"Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry","volume":"165","author":"Fonarow","year":"2005","journal-title":"Arch Intern Med"},{"key":"2026011921160683400_ejhfhft134-bib-0011","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jacc.2008.09.045","article-title":"Hospital variation and characteristics of implantable cardioverter defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines\u2013Heart Failure) registry","volume":"53","author":"Shah","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011921160683400_ejhfhft134-bib-0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","article-title":"The underutilization of cardiac medications of proven benefit, 1990 to 2002","volume":"41","author":"Stafford","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011921160683400_ejhfhft134-bib-0013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.108.772228","article-title":"Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF","volume":"1","author":"Fonarow","year":"2008","journal-title":"Circ Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0014","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","article-title":"EUR Observational Research Program: The Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"12","author":"Maggioni","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0015","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/eurheartj\/ehp359","article-title":"The European cardiac resynchronization therapy survey","volume":"30","author":"Dickstein","year":"2009","journal-title":"Eur Heart J"},{"key":"2026011921160683400_ejhfhft134-bib-0016","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/eurjhf\/hfp149","article-title":"Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008","volume":"11","author":"van Veldhuisen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0017","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardfail.2004.08.160","article-title":"Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry","volume":"11","author":"O\u2019Connor","year":"2005","journal-title":"J Card Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0018","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"2026011921160683400_ejhfhft134-bib-0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United Stated: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Survey (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"2026011921160683400_ejhfhft134-bib-0020","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"2026011921160683400_ejhfhft134-bib-0021","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehi845","article-title":"Nationwide survey on acute heart failure in cardiology ward services in Italy","volume":"27","author":"Tavazzi","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011921160683400_ejhfhft134-bib-0022","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011921160683400_ejhfhft134-bib-0023","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011921160683400_ejhfhft134-bib-0024","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jacc.2012.07.011","article-title":"Hospital patterns of use of positive inotropic agents in patients with heart failure","volume":"60","author":"Partovian","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011921160683400_ejhfhft134-bib-0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejheart.2005.07.002","article-title":"Practical recommendations for the use of ACEinhibitors, beta blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice","volume":"7","author":"McMurray","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0026","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurjhf\/hfr020","article-title":"Titration to target dose of bisoprololvs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial","volume":"13","author":"D\u00fcngen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0027","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/eurjhf\/hfs060","article-title":"Heart rateachieved or beta blocker dose in patients with chronic herat failure: which is the better target?","volume":"14","author":"Cullington","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921160683400_ejhfhft134-bib-0028","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume":"16","author":"Heart Failure Society of America","year":"2010","journal-title":"J Card Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhft134","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/15\/10\/1173\/66443394\/eurjhf_15_10_1173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/15\/10\/1173\/66443394\/eurjhf_15_10_1173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:19:46Z","timestamp":1768875586000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/15\/10\/1173\/8428771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,1,27]]},"published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hft134","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10,1]]}}}